Obstetric antiphospholipid syndrome: Has the black swan swallowed a red herring?

Journal of Rheumatology

Volumn 42, Issue 2, 2015, Pages 155-157

  Clark, Christine A ^c   Spitzer, Karen A ^a   Laskin, Carl A ^b  

^a One G   (United States)

^b UNIVERSITY OF TORONTO   (Canada)

^c Suite 1800   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CARDIOLIPIN ANTIBODY; HEPARIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID ANTIBODY;

ANTIPHOSPHOLIPID SYNDROME; DATA ANALYSIS; DISEASE ASSOCIATION; EDITORIAL; HIGH RISK POPULATION; HUMAN; MEDICAL SERVICE; MEDICAL SOCIETY; OUTCOME ASSESSMENT; PREDICTION; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SPONTANEOUS ABORTION; SYNDROME DELINEATION; THROMBOSIS; FEMALE; PREGNANCY; PREGNANCY COMPLICATIONS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS;

EID: 84923145478     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140760     Document Type: Editorial

References (25)

1. Hughes GR. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant. BMJ 1983;287:1088-9.
2. Harris EN. Syndrome of the black swan. Br J Rheumatol 1987;26:324-6.
3. th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome. Autoimmun Rev 2014;13:795-813.
4. Wilson WA, Gharavi AE, Koike T, Lockshin MD, Branch DW, Piette JC, et al. International consensus statement of preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11.
5. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006;4:295-306.
6. Branch DW, Silver RM, Porter TF. Obstetric antiphospholipid syndrome: current uncertainties should guide our way. Lupus 2010;19:446-52.
7. Bouvier S, Cochery-Nouvellon E, Lavigne-Lissalde G, Mercier E, Marchetti T, Balducchi JP, et al. Comparative incidence of pregnancy outcomes in treated obstetric antiphospholipid syndrome: the NOH-APS observational study. Blood 2014;123:404-13.
8. Kwak-Kim J, Agcaoili MS, Aleta L, Liao A, Ota K, Dambaeva S, et al. Management of women with recurrent pregnancy losses and antiphospholipid syndrome. Am J Reprod 2013:69:596-607.
9. Laskin CA, Bombardier C, Hannah ME, Mandel FP, Ritchie JW, Farewell V, et al. Prednisone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997;337:148-53.
10. Laskin CA, Spitzer KA, Clark CA, Crowther MR, Ginsberg JS, Hawker GA, et al. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the randomized controlled Hep/ASA trial. J Rheumatol 2009;36:279-87.
11. Carp HJ. Low molecular weight heparin and aspirin for recurrent pregnancy loss: results from the HepASA trial [letter; author reply]. J Rheumatol 2010;37:202-3.
12. American College of Obstetricians and Gynecologists. Management of recurrent early pregnancy loss. ACOG Practice Bulletin No. 24. 2001;24:1-8.
13. Jaslow CR, Carney JL, Kutteh WH. Diagnostic features identified in 1020 women with 2 versus three or more recurrent pregnancy losses. Fertil Steril 2010;93:1234-43.
14. Clark CA, Laskin CA, Spitzer KA. Anticardiolipin antibodies and recurrent early pregnancy loss: a century of equivocal evidence. Hum Reprod Update 2012;18:474-84.
15. Clark CA, Davidovitz J, Spitzer KA, Laskin CA. The lupus anticoagulant: results from 2257 patients attending a high-risk pregnancy clinic. Blood 2013;122:341-7.
16. Wahl D, Devignes J, Mohamed S, Zuily S, Lecompte T. Definition and significance of high positivity aCL ELISA. Lupus 2012;21:725-6.
17. Pengo V, Ruffatti A, Del Ross T, Tonello M, Cuffaro S, Hoxha A, et al. Confirmation of initial antiphospholipid antibody positivity depends on the antiphospholipid antibody profile. J Thrombosis Haemost 2013;11:1527-31.
18. Clark CA, Spitzer KA, Nadler JN, Laskin CA. Low aCL IgG titres in recurrent pregnancy loss signal the need for redefining APS [abstract]. Arthritis Rheum 2002;46 Suppl:S50.
19. Cohn DM, Goddijn M, Middledorp S, Korevaar JC, Dawood F, Farquharson RG. Recurrent miscarriage and antiphospholipid antibodies: prognosis of subsequent pregnancy. J Thrombo Haemost 2010;8:2208-13.
20. Lockshin MD, Kim M, Laskin CA, Guerra M, Branch DW, Merrill J, et al. Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies. Arthritis Rheum 2012;64:2311-8.
21. Clark CA, Spitzer KA, Crowther MA, Nadler JN, Laskin MD, Waks JA, et al. Incidence of postpartum thrombosis and preterm delivery in women with antiphospholipid antibodies and recurrent pregnancy loss. J Rheumatol 2007;34:992-6.
22. Sciascia S, Cosseddu D, Montaruli B, Kuzendo A, Bertero MT. Risk scale for the diagnosis of antiphospholipid syndrome. Ann Rheum Dis 2011;70:1517-8.
23. Cervera R, Serrano R, Pons-Estel GJ, Ceberio-Hualde L, Shoenfeld Y, de Ramón E, et al. Morbidity and mortality in the antiphospholipid syndrome during a 10-year period: a multicentre prospective study of 1000 patients. Ann Rheum Dis 2014; Jan 24 (E-pub ahead of print).
24. Winearls CG, Glassock RJ. Classification of chronic kidney disease in the elderly: pitfalls and errors. Nephron Clin Pract 2011;119 Suppl 1:c2-4.
25. Ruffatti A, Salvan E, Del Ross T, Gerosa M, Andreoli L, Maina A, et al. Treatment strategies and pregnancy outcomes in antiphospholipid syndrome patients with thrombosis and triple antiphospholipid positivity. A European multicentre retrospective study. Thromb Haemost 2014;112:727-35.